Company news

Share this article:
Cypress Pharmaceutical has entered into a multiple generic product development and marketing agreement with Standard Chem. & Pharm. Under the terms of the deal, Standard Chem. & Pharm. has the exclusive development and manufacturing rights and Cypress Pharmaceutical, Inc. has exclusive US marketing rights of generic drug products. Other financial terms of the agreement have not been disclosed.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.